Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market to Hit $302.3 Billion by 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The report “Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End-User, Organization Size, and Country: Forecast Trends and Growth Opportunity” has been added to from ResearchAndMarkets.com offer.

Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market to Grow 10.2% YoY with Total Addressable Market Capitalization of $30,233.3 Million During 2022-2031 Driven by Increase in Pipelines of drug candidates, growing demand for additional drug analytical details as well as process development by regulatory bodies, entry of new contracting organizations and lack of internal equipment as well as increasing adoption of drug candidate activities. outsourcing.

In-depth qualitative analyzes include the identification and investigation of the following aspects:

  • Market structure

  • Growth engines

  • Constraints and challenges

  • Emerging Product Trends and Market Opportunities

  • Porter’s Five Forces

On the basis of service type, the Asia-Pacific market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Bioanalytical tests

  • Clinical tests

  • Non-clinical trials

  • Method development and validation

  • Extractable and leachable

  • Impurity method

  • Technical advice

  • Other methods

  • Stability test

  • Drug testing

  • Accelerated stability testing

  • Photostability test

  • Other stability tests

  • Other services

On the basis of product, the Asia-Pacific market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Raw materials and additives

  • Active Pharmaceutical Ingredients (API)

  • Finished products

By end-user, the Asia-Pacific market is segmented into the following sub-markets with annual revenue (USD Million) for 2021-2031 included in each section.

  • Pharmaceutical and biopharmaceutical companies

  • Contract Manufacturing Organizations (CMOs)

  • Other end users

By organization size, the Asia-Pacific market is segmented into the following submarkets with annual revenue (USD Million) for 2021-2031 included in each section.

Geographically, the following national/local markets are fully investigated:

  • Japan

  • China

  • South Korea

  • Australia

  • India

  • Rest of APAC (segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan and Philippines)

Main topics covered:

1. Introduction

2 Market Overview and Dynamics

3 Asia-Pacific Market Segmentation by Service Type

4 Asia-Pacific Market Segmentation by Product Type

5 Asia-Pacific Market Segmentation by End User

6 Asia-Pacific Market Segmentation by Organization Size

7 Asia-Pacific Market 2021-2031 by Countries

8 Competitive Landscape

Companies cited

  • Boston Analytical, Inc.

  • Charles River International Laboratories, Inc.

  • Eurofins Scientific SE

  • Exova Group PLC

  • Intertek Pharmaceutical Services

  • Testing laboratory inc.

  • Pace Analytical Services LLC

  • Pharmaceutical Product Development, LLC

  • SGS S.A.

  • Steris PLC

  • Tentamus

  • Toxicon inc.

  • West Pharmaceutical Services Inc.

  • WuXi AppTec, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/2vyuk5